Transitioning from One GLP-1 to Another

The one question that matters

People switch compounds for many reasons: a plateau on the current one, side effects, cost, availability, or wanting the additional receptor activity of a newer compound. Whatever the reason, the switch itself is rarely the hard part. Your body already knows what incretin signaling feels like—appetite suppression, quieter food noise, slower gastric emptying. You are not starting over.

The conservative default—and its cost

The most conservative approach is to start at the very bottom of the new compound’s titration schedule, exactly as if you had never used a GLP-1 before. That is the safest option for side effects, and it is never wrong.

But it has a real cost. If you were at an effective dose of the previous compound, dropping to a first-timer starting dose can mean many difficult months: appetite and food noise return, progress stalls, and you slowly titrate back up to a dose that actually works. For someone who was already well past the starting steps, that is a long detour.

The rule of thirds

A more practical approach: break the previous compound’s dosing range into thirds, find which third your current dose sits in, and let that decide where you enter the new compound’s schedule.

The logic is simple: your position in the old range is a rough measure of how much incretin signaling your body is already adapted to. Someone in the bottom third has little adaptation to carry over, so they start at the bottom. Someone in the middle or top third can safely skip the introductory step—but nobody needs to enter a new compound near the top of its range, because compounds differ and the only way to know how the new one hits you is to test it.

The three schedules, side by side

These are the reference titration schedules used in the compound guides on this site, with the standard FDA schedule for Semaglutide. Each row is one step; the shading of thirds follows the steps.

To use the rule: find your current dose in its column, note the range position, then read the starting dose from the new compound’s column—step 1 for the bottom third, step 2 for the middle third, and step 2 or 3 for the top third.

Quick conversion tables

Switching to Retatrutide

Switching to Tirzepatide

Worked examples

After the switch

Once you have entered the new schedule, treat your entry point as if it were your current titration step and follow the normal golden rules from the compound guides:

1. Hold your entry doseStay at the starting level long enough to see how the new compound actually affects you—appetite, food noise, and side effects—before increasing.
2. Increase only when neededIf the entry dose already gives solid appetite control, there is no reason to climb. The goal is the lowest effective dose, not matching your old dose number.
3. Step back if side effects appearIf nausea, reflux, or fatigue shows up at your entry point, drop to the previous step of the schedule and stabilize. That is data, not failure.
4. Change one variable at a timeDo not switch compounds and overhaul diet, training, or sleep in the same window—you will not know what caused a change in appetite or side effects.

Quick-reference checklist

• Identify your current dose and which third of the old compound’s range it sits in.
• Bottom third → start the new compound at step 1.
• Middle third → start at step 2.
• Top third → start at step 2 or 3, likely step 2 to test effects.
• Swap at the next scheduled dose; never run both compounds at once.
• Hold the entry dose long enough to judge the real response.
• Titrate up from there only if appetite or food noise returns.

Related research